In patients with chronic kidney disease and those on dialysis, what are the expected baseline serum tryptase levels compared to normal reference ranges, and how useful is tryptase in diagnosing dialyzer reactions and other clinical conditions in this population?

Fuente: Zenodo
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Tripdatabase
Format: Recurso digital
Veröffentlicht: Zenodo 2026
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866902154010165248
author Tripdatabase
author_facet Tripdatabase
contents Tryptase levels in patients with chronic kidney disease, including those on dialysis, are generally elevated above normal reference ranges. However, specific studies addressing its use for diagnosing dialyzer reactions are lacking.
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_20403014
institution Zenodo
language
publishDate 2026
publisher Zenodo
record_format zenodo
spellingShingle In patients with chronic kidney disease and those on dialysis, what are the expected baseline serum tryptase levels compared to normal reference ranges, and how useful is tryptase in diagnosing dialyzer reactions and other clinical conditions in this population?
Tripdatabase
chronic kidney disease
dialysis
serum tryptase
diagnosis
dialyzer reactions
clinical conditions
nephrology
pathology
Tryptase levels in patients with chronic kidney disease, including those on dialysis, are generally elevated above normal reference ranges. However, specific studies addressing its use for diagnosing dialyzer reactions are lacking.
title In patients with chronic kidney disease and those on dialysis, what are the expected baseline serum tryptase levels compared to normal reference ranges, and how useful is tryptase in diagnosing dialyzer reactions and other clinical conditions in this population?
topic chronic kidney disease
dialysis
serum tryptase
diagnosis
dialyzer reactions
clinical conditions
nephrology
pathology
url https://doi.org/10.5281/zenodo.20403014